𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: A review

✍ Scribed by Masterson, Timothy A.; Rice, Kevin R.; Beck, Stephen D.W.


Book ID
123424397
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
300 KB
Volume
32
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic risk factors in low stage tes
✍ Axel Heidenreich; Isabell A. Sesterhenn; Judd W. Moul πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

I n their report, Albers et al. 1 present data on the potential clinical utility of immunohistochemical expression of Ki-67 in clinical Stage I nonseminomatous testicular germ cell tumors (NSGCT) to predict a group of patients at low risk for occult metastatic disease. Using a cutoff value of Γ΅70% M

Flow-cytometric and quantitative histolo
✍ Werner T. W. de Riese; Cornelia de Riese; Thomas M. Ulbright; Edwin B. Walker; J πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 601 KB

Our study was performed to clarify whether the combination of DNA flow-cytornetric and quantitative histopathological parameters improves the prediction of occult metastatic disease in clinical stage-I non-seminomatous testicular germ-cell tumors (NSGCT). We used archival paraffin primary-tumor tiss